DeusPowershop

Post-cycle therapy (PCT) explained

Updated 2026-04-30 · Reviewed by the DeusPowershop editorial team

Post-cycle therapy is the protocol an athlete runs after a cycle of anabolic-androgenic steroids or suppressive SARMs to restart endogenous testosterone production. It is the single most important determinant of long-term endocrine health for anyone who uses these compounds. For background see the post-cycle therapy article on Wikipedia and the 2015 review of anabolic-steroid-induced hypogonadism (PMC4744102).

What suppression actually means

The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses. GnRH triggers the pituitary to release LH and FSH. LH stimulates Leydig cells in the testes to make testosterone; FSH supports spermatogenesis. Exogenous androgens — and to a lesser extent SARMs — feed back negatively on the hypothalamus, shutting off GnRH. Within a few weeks LH and FSH are at the floor and endogenous testosterone production stops.

The four classes of PCT drug

A standard 4-week SERM PCT

Start once active compound has cleared (see the timing FAQ above). The most-published protocol:

Week Clomid Nolvadex
150 mg/day40 mg/day
250 mg/day40 mg/day
325 mg/day20 mg/day
425 mg/day20 mg/day

For lighter SARM-only cycles a single SERM at half these doses for 4 weeks is usually enough. For long or harsh cycles, hCG 250–500 IU twice weekly for 2–4 weeks before SERM-PCT helps restore Leydig-cell sensitivity.

Bloodwork is not optional

The only honest way to confirm a PCT worked is comparative bloodwork. A minimal panel:

What goes wrong

Where to go next

Sources